Sopharma

Effects of COVID-19 on Sopharma

Current COVID-19 pandemic has already affected all participants in the Bulgarian economy. For Sopharma, this has led to increased demand for specific groups of medicines, including quinin-based medical products for fighting COVID-19, whose export was banned temporarily by the Bulgarian minister of healthcare with the aim of guaranteeing the local needs for this medicine.



Lyubomir Minchev, majority shareholder in TBS Group (photo: Telelink)

TBS Group will offer first tranche of shares as of 27 January

ICT-focused Telelink Business Services Group (TBS Group) will offer its up to 30% of shares on the Bulgarian Stock Exchange in two tranches. The first one will last from 27th Jan’20 to 31st Jan’20, and the second one will be held in the second half of Sep’20.